CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea - Arias, M. A.; García-Río, F.; Alonso-Fernández, A.; Hernanz, Á.; Hidalgo, R.; Martínez-Mateo, V.; Bartolomé, S.; Rodríguez-Padial, L. (The European respiratory journal, 2008)
Keywords: Adult; Biological and medical sciences; Continuous Positive Airway Pressure; Cross-Over Studies; Double-Blind Method; Epinephrine - urine; Humans; Interleukin-6 - blood; Leukotriene B4 - blood; Male; Medical sciences; Middle Aged; Norepinephrine - urine; Placebos; Pneumology; Prospective Studies; Receptors, Tumor Necrosis Factor, Type I - blood; Respiratory system : syndromes and miscellaneous diseases; Sleep Apnea, Obstructive - blood; Sleep Apnea, Obstructive - therapy; Tumor Necrosis Factor-alpha - blood; Nervous system diseases; Sleep apnea syndrome; Respiratory disease; Continuous; Continuous positive airway pressure; Inflammation; Artificial ventilation; obstructive sleep apnoea; Blood plasma; Decrease; Positive pressure; Mechanical ventilation; Tumor necrosis factor α; Pneumology; Biological receptor